Jun Shi

Mr. Jun Shi


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2017 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
SWShiying Wang
Shiying Wang
XZXinxin Zhao
Xinxin Zhao
SYSuxia Yang
Suxia Yang
BCBaoping Chen
Baoping Chen
JSJun Shi
Jun Shi

1 September 2018 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
ZSZhiqiang Sun
Zhiqiang Sun
YMYali Ma
Yali Ma
FCFang Chen
Fang Chen
SWShiying Wang
Shiying Wang
BCBaoping Chen
Baoping Chen
JSJun Shi
Jun Shi

2 August 2019 in Phytotherapy Research
Verified
Journal Article
Closed access
PDF file
JBJin Bai
Jin Bai
YWYi Wang
Yi Wang
XZXiaoguang Zhu
Xiaoguang Zhu
JSJun Shi
Jun Shi

1 January 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
SWShiying Wang
Shiying Wang
ZSZhiqiang Sun
Zhiqiang Sun
SYSuxia Yang
Suxia Yang
BCBaoping Chen
Baoping Chen
JSJun Shi
Jun Shi

7 August 2019 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Open access
LQLinfang Qin
Linfang Qin
RZRuimin Zhang
Ruimin Zhang
SYSuxia Yang
Suxia Yang
FCFang Chen
Fang Chen
JSJun Shi
Jun Shi
Diabetic nephropathy (DN) is one of the major diabetic complications that lead to end-stage renal failure. Angiopoietin-like protein-4 (ANGPTL-4) has been reported to be dysregulated in diabetes mellitus and diabetic complications. However, the role of ANGPTL-4 in glomerular mesangial cells (MCs) during DN remains unclear. In the present study, we evaluated the role of ANGPTL-4 in MCs in response to high glucose (HG) condition and the potential mechanism. The results proved that ANGPTL-4 expression is significantly increased in HG-stimulated MCs. Knockdown of ANGPTL-4 suppressed HG-induced cell proliferation of MCs. The production of pro-inflammatory cytokines including TNF-α, IL-1β, IL-6 were decreased in ANGPTL-4 knocked down MCs. Inhibition of ANGPTL-4 markedly suppressed the expressions of extracellular matrix (ECM) proteins, collagen IV (Col IV) and fibronectin (FN), in HG-stimulated MCs. Furthermore, ANGPTL-4 knockdown inhibited the HG-induced activation of NF-κB signaling pathway in MCs. Collectively, knockdown of ANGPTL-4 suppressed HG-induced cell proliferation, inflammatory response, and ECM accumulation inhibiting NF-κB signaling pathway in MCs. These findings suggested that ANGPTL-4 might be a therapeutic target for the prevention and treatment of DN.

14 January 2019 in RSC Advances
Verified
Journal Article
Open access
PDF file
YWYunqian Wang
Yunqian Wang
LXLei Xue
Lei Xue
HLHuicong Li
Huicong Li
JSJun Shi
Jun Shi
BCBaoping Chen
Baoping Chen
Forkhead box O 6 (FOXO6), a FOX transcription factor, has been found to be involved in diabetes mellitus and related complications. However, the role of FOXO6 in diabetic nephropathy (DN) has not been fully understood. In the present study, we evaluated the functions of FOXO6 in high glucose (HG)-induced glomerular mesangial cells (MCs). The results showed that FOXO6 expression was significantly elevated in MCs after HG stimulation. Knockdown of FOXO6 by transfection with small interfering RNA (siRNA) targeting FOXO6 (siRNA-FOXO6) suppressed cell proliferation in MCs. The productions of extracellular matrix (ECM) components including collagen IV (Col IV) and fibronectin (FN) were markedly decreased after FOXO6 knockdown in MCs. Furthermore, knockdown of FOXO6 inhibited HG-induced activation of p38 MAPK signaling pathway in MCs. Collectively, these findings suggested that knockdown of FOXO6 inhibited cell proliferation and ECM accumulation in HG-induced MCs via inhibiting p38 MAPK signaling pathway. FOXO6 might be a beneficial therapeutic target for the prevention and treatment of DN.